SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-064704
Filing Date
2021-12-10
Accepted
2021-12-10 16:15:26
Documents
5
Period of Report
2021-12-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea152145-6k_universepharma.htm 6-K 13876
2 STRATEGIC COOPERATION AGREEMENT BY AND BETWEEN UNIVERSE PHARMACEUTICALS INC AND ea152145ex1-1_universepharma.htm EX-1.1 66910
3 SHARE PURCHASE AGREEMENT BY AND AMONG UNIVERSE PHARMACEUTICALS INC, KITANIHON PH ea152145ex1-2_universepharma.htm EX-1.2 26020
4 COOPERATION AGREEMENT ON MANUFACTURING FACILITY CONSTRUCTION PROJECT BY AND BETW ea152145ex1-3_universepharma.htm EX-1.3 49210
5 SHARE TRANSFER AGREEMENT BY AND AMONG SUNUNION HOLDING GROUP LTD., KITANIHON PHA ea152145ex1-4_universepharma.htm EX-1.4 38633
  Complete submission text file 0001213900-21-064704.txt   195744
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 211485473
SIC: 2834 Pharmaceutical Preparations